396 related articles for article (PubMed ID: 15806155)
1. CXCR4 chemokine receptor and integrin signaling co-operate in mediating adhesion and chemoresistance in small cell lung cancer (SCLC) cells.
Hartmann TN; Burger JA; Glodek A; Fujii N; Burger M
Oncogene; 2005 Jun; 24(27):4462-71. PubMed ID: 15806155
[TBL] [Abstract][Full Text] [Related]
2. Functional expression of CXCR4 (CD184) on small-cell lung cancer cells mediates migration, integrin activation, and adhesion to stromal cells.
Burger M; Glodek A; Hartmann T; Schmitt-Gräff A; Silberstein LE; Fujii N; Kipps TJ; Burger JA
Oncogene; 2003 Nov; 22(50):8093-101. PubMed ID: 14603250
[TBL] [Abstract][Full Text] [Related]
3. The role of adhesion molecules and chemokine receptor CXCR4 (CD184) in small cell lung cancer.
Hartmann TN; Burger M; Burger JA
J Biol Regul Homeost Agents; 2004; 18(2):126-30. PubMed ID: 15471215
[TBL] [Abstract][Full Text] [Related]
4. CXCR4 chemokine receptor engagement modifies integrin dependent adhesion of renal carcinoma cells.
Jones J; Marian D; Weich E; Engl T; Wedel S; Relja B; Jonas D; Blaheta RA
Exp Cell Res; 2007 Nov; 313(19):4051-65. PubMed ID: 17706641
[TBL] [Abstract][Full Text] [Related]
5. Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo.
Sethi T; Rintoul RC; Moore SM; MacKinnon AC; Salter D; Choo C; Chilvers ER; Dransfield I; Donnelly SC; Strieter R; Haslett C
Nat Med; 1999 Jun; 5(6):662-8. PubMed ID: 10371505
[TBL] [Abstract][Full Text] [Related]
6. Involvement of chemokine receptor 4/stromal cell-derived factor 1 system during osteosarcoma tumor progression.
Perissinotto E; Cavalloni G; Leone F; Fonsato V; Mitola S; Grignani G; Surrenti N; Sangiolo D; Bussolino F; Piacibello W; Aglietta M
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):490-7. PubMed ID: 15701832
[TBL] [Abstract][Full Text] [Related]
7. Stromal cell-derived factor-1 enhances motility and integrin up-regulation through CXCR4, ERK and NF-kappaB-dependent pathway in human lung cancer cells.
Huang YC; Hsiao YC; Chen YJ; Wei YY; Lai TH; Tang CH
Biochem Pharmacol; 2007 Dec; 74(12):1702-12. PubMed ID: 17904532
[TBL] [Abstract][Full Text] [Related]
8. Extracellular matrix regulation of drug resistance in small-cell lung cancer.
Rintoul RC; Sethi T
Clin Sci (Lond); 2002 Apr; 102(4):417-24. PubMed ID: 11914104
[TBL] [Abstract][Full Text] [Related]
9. Stromal cell-derived factor-1/CXCR4 enhanced motility of human osteosarcoma cells involves MEK1/2, ERK and NF-kappaB-dependent pathways.
Huang CY; Lee CY; Chen MY; Yang WH; Chen YH; Chang CH; Hsu HC; Fong YC; Tang CH
J Cell Physiol; 2009 Oct; 221(1):204-12. PubMed ID: 19496172
[TBL] [Abstract][Full Text] [Related]
10. Immature leukemic CD34+CXCR4+ cells from CML patients have lower integrin-dependent migration and adhesion in response to the chemokine SDF-1.
Peled A; Hardan I; Trakhtenbrot L; Gur E; Magid M; Darash-Yahana M; Cohen N; Grabovsky V; Franitza S; Kollet O; Lider O; Alon R; Rechavi G; Lapidot T
Stem Cells; 2002; 20(3):259-66. PubMed ID: 12004084
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of CXCR4 expression in PC-3 cells by stromal-derived factor-1alpha (CXCL12) increases endothelial adhesion and transendothelial migration: role of MEK/ERK signaling pathway-dependent NF-kappaB activation.
Kukreja P; Abdel-Mageed AB; Mondal D; Liu K; Agrawal KC
Cancer Res; 2005 Nov; 65(21):9891-8. PubMed ID: 16267013
[TBL] [Abstract][Full Text] [Related]
12. Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis.
Kucia M; Reca R; Miekus K; Wanzeck J; Wojakowski W; Janowska-Wieczorek A; Ratajczak J; Ratajczak MZ
Stem Cells; 2005 Aug; 23(7):879-94. PubMed ID: 15888687
[TBL] [Abstract][Full Text] [Related]
13. Expression of beta 1, beta 3, beta 4, and beta 5 integrins by human lung carcinoma cells of different histotypes.
Falcioni R; Cimino L; Gentileschi MP; D'Agnano I; Zupi G; Kennel SJ; Sacchi A
Exp Cell Res; 1994 Jan; 210(1):113-22. PubMed ID: 7505746
[TBL] [Abstract][Full Text] [Related]
14. Stromal cell-derived factor-1 and CXCR4 receptor interaction in tumor growth and metastasis of breast cancer.
Dewan MZ; Ahmed S; Iwasaki Y; Ohba K; Toi M; Yamamoto N
Biomed Pharmacother; 2006 Jul; 60(6):273-6. PubMed ID: 16828253
[TBL] [Abstract][Full Text] [Related]
15. Involvement of matrix metalloproteinase-9 in stromal cell-derived factor-1/CXCR4 pathway of lung cancer metastasis.
Tang CH; Tan TW; Fu WM; Yang RS
Carcinogenesis; 2008 Jan; 29(1):35-43. PubMed ID: 17916907
[TBL] [Abstract][Full Text] [Related]
16. [Effects of anti-CXCR4 monoclonal antibody on adhesion and proliferation of human acute myelocytic leukemia cell line HL-60].
Wei L; Kong PY; Chen XH; Peng XG; Zeng DF; Chang C; Yang WB; Liu H; Liu L; Wang QY; Zhang Y
Ai Zheng; 2004 Nov; 23(11):1273-7. PubMed ID: 15522172
[TBL] [Abstract][Full Text] [Related]
17. CXCR4 chemokine receptor mediates prostate tumor cell adhesion through alpha5 and beta3 integrins.
Engl T; Relja B; Marian D; Blumenberg C; Müller I; Beecken WD; Jones J; Ringel EM; Bereiter-Hahn J; Jonas D; Blaheta RA
Neoplasia; 2006 Apr; 8(4):290-301. PubMed ID: 16756721
[TBL] [Abstract][Full Text] [Related]
18. Cell surface tetraspanin CD9 mediates chemoresistance in small cell lung cancer.
Kohmo S; Kijima T; Otani Y; Mori M; Minami T; Takahashi R; Nagatomo I; Takeda Y; Kida H; Goya S; Yoshida M; Kumagai T; Tachibana I; Yokota S; Kawase I
Cancer Res; 2010 Oct; 70(20):8025-35. PubMed ID: 20940407
[TBL] [Abstract][Full Text] [Related]
19. Integrin alpha4beta1 involvement in stromal cell-derived factor-1alpha-promoted myeloma cell transendothelial migration and adhesion: role of cAMP and the actin cytoskeleton in adhesion.
Parmo-Cabañas M; Bartolomé RA; Wright N; Hidalgo A; Drager AM; Teixidó J
Exp Cell Res; 2004 Apr; 294(2):571-80. PubMed ID: 15023543
[TBL] [Abstract][Full Text] [Related]
20. Repetitive nicotine exposure leads to a more malignant and metastasis-prone phenotype of SCLC: a molecular insight into the importance of quitting smoking during treatment.
Martínez-García E; Irigoyen M; González-Moreno O; Corrales L; Teijeira A; Salvo E; Rouzaut A
Toxicol Sci; 2010 Aug; 116(2):467-76. PubMed ID: 20457658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
